Literature DB >> 21686675

Painful neuropathy with skin denervation after prolonged use of linezolid.

Chi-Chao Chao1, Hsin-Yun Sun, Yang-Chyuan Chang, Sung-Tsang Hsieh.   

Abstract

The prolonged use of linezolid, a new antibiotic against drug-resistant Gram-positive pathogens, might cause painful neuropathy. This finding raises the possibility that small-diameter sensory nerves in the skin, which are responsible for transmitting nociceptive information, might be affected. We report a 53-year-old female who developed pure small-fibre painful neuropathy (visual analogue scale, VAS =82 on 0-100 scale) with marked skin denervation in the leg (epidermal nerve density, END =2.32 fibres/mm, norm <5.88 fibres/mm) and significant elevation of the warm threshold in the foot (40.0°C, norm <39.4°C) after the use of linezolid for 6 months. Eight months after the discontinuation of linezolid, the skin became fully reinnervated (END =9.04 fibres/mm), with disappearance of neuropathic pain (VAS =0) and normalisation of the warm threshold (36.3°C). Nerve conduction studies for large-diameter motor and sensory nerves were normal. This report documents a pure small-fibre sensory neuropathy after prolonged use of linezolid, and the relationship between skin innervation and corresponding neuropathic pain.

Entities:  

Year:  2009        PMID: 21686675      PMCID: PMC3029234          DOI: 10.1136/bcr.08.2008.0702

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

Review 1.  Sensory nerves in skin: answers about painful feet?

Authors:  W R Kennedy; G Said
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

2.  Linezolid-induced neuropathy.

Authors:  L Legout; E Senneville; J J Gomel; Y Yazdanpanah; Y Mouton
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

3.  Severe sensory neuropathy associated with long-term linezolid use.

Authors:  Sasa A Zivkovic; David Lacomis
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

Review 4.  Linezolid: a review of its use in the management of serious gram-positive infections.

Authors:  C M Perry; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Pathology of nerve terminal degeneration in the skin.

Authors:  S T Hsieh; H Y Chiang; W M Lin
Journal:  J Neuropathol Exp Neurol       Date:  2000-04       Impact factor: 3.685

6.  Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations.

Authors:  Chun-Liang Pan; To-Jung Tseng; Yea-Huey Lin; Ming-Chang Chiang; Whei-Min Lin; Sung-Tsang Hsieh
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

7.  Linezolid-associated peripheral neuropathy.

Authors:  Jennifer P Rho; Irene G Sia; Brian A Crum; Mark B Dekutoski; Robert T Trousdale
Journal:  Mayo Clin Proc       Date:  2004-07       Impact factor: 7.616

8.  Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments.

Authors:  Chia-Tung Shun; Yang-Chyuan Chang; Huey-Peir Wu; Song-Chou Hsieh; Whei-Min Lin; Yea-Hui Lin; Tong-Yuan Tai; Sung-Tsang Hsieh
Journal:  Brain       Date:  2004-05-05       Impact factor: 13.501

9.  Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.

Authors:  Mary C Birmingham; Craig R Rayner; Alison K Meagher; Susan M Flavin; Donald H Batts; Jerome J Schentag
Journal:  Clin Infect Dis       Date:  2003-01-03       Impact factor: 9.079

10.  Linezolid-associated toxic optic neuropathy: a report of 2 cases.

Authors:  Elsie Lee; Susanne Burger; Jilan Shah; Christine Melton; Michael Mullen; Floyd Warren; Robert Press
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.